Magenta Therapeutics Announces Pricing of Public Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 1, 2019--Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative p…
CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 1, 2019--Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative p…